# Staccato Alprazolam Single Dose PK

> **NCT00444522** · PHASE1 · COMPLETED · sponsor: **Alexza Pharmaceuticals, Inc.** · enrollment: 50 (—)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Alprazolam thermal aerosol

## Key facts

- **NCT ID:** NCT00444522
- **Lead sponsor:** Alexza Pharmaceuticals, Inc.
- **Sponsor class:** UNKNOWN
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2005-08
- **Final completion:** 2005-08
- **Target enrollment:** 50 (—)
- **Last updated:** 2017-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00444522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00444522, "Staccato Alprazolam Single Dose PK". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00444522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*